Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Phenomenex Launches Innovative, Industry-Focused Websites

Published: Friday, February 22, 2013
Last Updated: Friday, February 22, 2013
Bookmark and Share
Company builds on award-winning web presence with new digital experience.

Phenomenex Inc. announces an entirely new "Smart Web" design, organized for the key industries the company serves. Redesigned from the ground up, the industry-specific gateways function as complete digital consultants, helping users find answers by providing customized content and newsletters along with product selection and method development tools.

Already recognized as an innovator in web design, Phenomenex has created the new industry sites to address overall user movement toward researching, purchasing and applying products completely with web tools. The digital experience is designed to anticipate customer needs and questions.
 
"Smart Web" industry-specific sites are now live for pharmaceutical, food and beverage, clinical research, environmental, forensic toxicology and fuels customers.

"We have customers across the globe, working at all hours, who are searching online for answers. We wanted to give them the same high level of support and service in the digital space that they have come to expect when working with us in person," explains Michael Garriques, Internet marketing manager at Phenomenex. "They want immediate information to help them quickly figure out which column is best for their application, purchase that column and then develop the most effective methods for their compounds. Our in-house web team has broken new ground and created an easy-to-use 'digital experience' designed to give customers the answers they need from anywhere at anytime."

In 2011, Phenomenex received the award for best biotechnology website in the Web Marketing Association's Web Award competition. The Phenomenex web tools are available across platforms and across languages including Chinese and Korean. The company has been regularly developing new web tools that enhance the user experience. Phenomenex's proprietary structure search capability, enhanced last year, enables researchers to find a method by simply drawing the chemical structure - something that is second nature to them. In addition to saving time, this approach is easy for researchers at all experience levels and, because chemical structures are universal throughout the world, it is equally convenient for users in all countries.

"Structure Search is a nice addition to your already excellent application search tools. Phenomenex has become my first web stop when searching for GC and LC applications in our lab. Kudos," commented Brandon Doss  of Algenol Biofuels.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Phenomenex and USP Offer Workshop on Practical Application of Chapter <621>
Half-Day Course at Pittcon Will Help Labs Develop Method Adjustments for Greater Stability and Productivity
Monday, February 15, 2010
Phenomenex Introduces www.strataSPE.com: Interactive Solutions for Sample Preparation
This website contains the latest information on SPE products, techniques, applications, and method development.
Thursday, April 13, 2006
Scientific News
Promising Class of New Cancer Drugs Cause Memory Loss in Mice
New findings from The Rockefeller University suggest that the original version of BET inhibitors causes molecular changes in mouse neurons, and can lead to memory loss in mice that receive it.
Electrical Control of Cancer Cells
Research led by scientists at The University of Texas Health Science Center at Houston (UTHealth) has revealed a new electrical mechanism that can control these switches.
Signature of Microbiomes Linked to Schizophrenia
Studying microbiomes in throat may help identify causes and treatments of brain disorder.
Inflammation Linked to Colon Cancer Metastasis
A new Arizona State University research study led by Biodesign Institute executive director Raymond DuBois has identified for the first time the details of how inflammation triggers colon cancer cells to spread to other organs, or metastasize.
Structural Discoveries Could Aid in Better Drug Design
Scientists have uncovered the structural details of how some proteins interact to turn two different signals into a single integrated output.
Determining the Age of Fingerprints
Watch the imprint of a tire track in soft mud, and it will slowly blur, the ridges of the pattern gradually flowing into the valleys. Researchers have tested the theory that a similar effect could be used to give forensic scientists a way to date fingerprints.
Genetic Overlapping in Multiple Autoimmune Diseases May Suggest Common Therapies
CHOP genomics expert leads analysis of genetic architecture, with eye on repurposing existing drugs.
Surprising Mechanism Behind Antibiotic-Resistant Bacteria Uncovered
Now, scientists at TSRI have discovered that the important human pathogen Staphylococcus aureus, develops resistance to this drug by “switching on” a previously uncharacterized set of genes.
Tissue Bank Pays Dividends for Brain Cancer Research
Checking what’s in the bank – the Brisbane Breast Bank, that is – has paid dividends for UQ cancer researchers.
Researchers Publish Landmark “Basket Study”
Researchers from Memorial Sloan Kettering Cancer Center (MSK) have announced results from the first published basket study, a new form of clinical trial design that explores responses to drugs based on the specific mutations in patients’ tumors rather than where their cancer originated.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!